Clinical Trial Update: Systematic Withdrawal of Neurohumoral Blocker Therapy in Optimally Responding CRT Patients [Phase 4]

View source ↗

Summary

Phase 4 trial updating systematic withdrawal of neurohumoral blocker therapy in optimally responding CRT patients with heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: Hasselt University | Conditions: Heart Failure (HF) | Phase 4 | Status: COMPLETED